Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma

  • Matthias Kruse, Bernd Rosenkranz, Clair Dobson, Gareth Ayre, Ann Horowitz
  • Pulmonary Pharmacology & Therapeutics, June 2005, Elsevier
  • DOI: 10.1016/j.pupt.2004.12.011

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Bernd Rosenkranz